Trials / Sponsors / REMD Biotherapeutics, Inc.
REMD Biotherapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab Type 1 Diabetes Mellitus | Phase 1 | 2024-02-15 |
| Completed | Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Type1 Diabetes Mellitus | Phase 2 | 2017-09-19 |
| Completed | Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 D Type 1 Diabetes Mellitus, Diabetes | Phase 1 | 2016-03-01 |
| Completed | Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in S Type 2 Diabetes Mellitus, Diabetes | Phase 1 / Phase 2 | 2015-09-01 |